This role sits at the forefront of oncology commercialization, focusing on shaping and executing impactful marketing strategies for innovative therapies targeting pancreatic ductal adenocarcinoma. The Associate Director will play a key role in preparing and driving launch excellence for a pipeline of transformative RAS(ON) inhibitors in a highly competitive and rapidly evolving oncology landscape. Working within a cross-functional commercial organization, this leader will translate deep customer and market insights into compelling brand strategies and omnichannel execution plans. The role requires close collaboration with medical affairs, clinical development, market access, and external agencies to ensure alignment across all stakeholder touchpoints. With strong exposure to KOLs, healthcare providers, and patient ecosystems, this position is both strategic and execution-focused. It offers the opportunity to directly influence how breakthrough oncology treatments reach patients in need.